Monitor the November 10, 2026 shareholder vote on the reverse stock split — approval is critical for NYSE continued listing. The stock closed at $0.84 on June 30, 2026, well below the $1.00 threshold. Post-split, watch for sustained trading above $1.00 for 30 consecutive trading days to cure the deficiency. Also track FY2027 Q1 earnings for revenue and cash flow trends, as FY2026 revenue missed original targets.
Price Chart
Executive Summary
SelectQuote's 2026 definitive proxy statement includes a reverse stock split proposal (1-for-10 to 1-for-20) to regain NYSE compliance after receiving a deficiency notice on March 19, 2026 for trading below $1.00. The company reported FY2026 net income of $62.2 million, up from $47.6 million in FY2025, and generated $31.9 million in operating cash flow. CEO Timothy Danker received total compensation of $2.9 million, down from $3.5 million in FY2025, while the stock declined from $1.74 at grant date to $0.84 at fiscal year-end.
Key Facts
- Proposal to effect a reverse stock split at a ratio between 1-for-10 and 1-for-20 to cure NYSE non-compliance (average closing price below $1.00 over 30 consecutive trading days as of March 19, 2026)
- FY2026 net income of $62.2 million vs $47.6 million in FY2025
- FY2026 revenue of $1.618 billion vs target of $1.714 billion (94% of target)
- FY2026 Adjusted EBITDA of $109.1 million vs target of $109.1 million (100% of target)
- FY2026 operating cash flow of $31.9 million vs target of $26.7 million (119% of target)
- CEO Timothy Danker FY2026 total compensation: $2,899,920 (down from $3,487,527 in FY2025)
- President Robert Grant FY2026 total compensation: $2,460,948 (down from $3,063,841)
- COO William Grant III FY2026 total compensation: $2,176,709 (down from $2,723,982)
- Compensation Actually Paid to PEO (Timothy Danker) for FY2026: -$920,990 (negative due to equity value decline)
- Stock price at June 30, 2026: $0.84 per share; grant-date price for FY2026 equity awards: $1.74
- Last say-on-pay vote received >96% approval
- Board recommends FOR all proposals including reverse stock split, say-on-pay, auditor ratification, and adjournment
- Annual Meeting scheduled for November 10, 2026
Financial Impact
Reverse stock split at 1:10-1:20 ratio would reduce outstanding shares from 179.3M to between 17.9M and 9.0M; authorized shares would reduce from 700M to between 70M and 35M. FY2026 net income of $62.2M on revenue of $1.618B.
Risk Factors
- Reverse stock split may not increase stock price proportionally or sustain above $1.00, risking NYSE delisting
- Revenue of $1.618B missed original target of $1.714B (94% of target), indicating top-line pressure
- Stock price declined 52% from grant-date ($1.74) to fiscal year-end ($0.84), significantly reducing equity award values
- Compensation Actually Paid to CEO was negative (-$920,990) due to equity value decline, signaling misalignment with shareholder returns
- Pharmacy reimbursement rate changes impacted Healthcare Services division margins and required mid-year target adjustments
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001794783-26-000065 |
| Document: 0001794783-26-000065-index-headers.html | 0001794783-26-000065 |
| Document: 0001794783-26-000065-index.html | 0001794783-26-000065 |
| Document: 0001794783-26-000065.txt | 0001794783-26-000065 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | DEFA14A | $0.4260 | awaiting T+60 | — | $0.3271 (−23.22%) |
Sep 30, 2026 26d ago | DEF 14A | $0.4260 | awaiting T+60 | — | $0.3271 (−23.22%) |
Aug 25, 2026 8w ago | 8-K | $0.5483 | awaiting T+60 | — | $0.3271 (−40.34%) |
Jun 11, 2026 19w ago | Institutional Cluster | $0.9165 $0.5362 | ▲ +41.49% | ▲ +45.89% | $0.3271 (+64.31%) |
May 5, 2026 24w ago | 8-K | $1.24 $0.7266 | ▼ −41.40% | ▼ −44.14% | $0.3271 (−73.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers